This report from Life Science Intelligence provides the latest market data for the Global Cryoablation Devices Market. Information covered by this report includes:
The global market for cryoablation devices was valued at an estimated $183 million in 2020 and is projected to increase at a CAGR (2020-2024) of 12.6%..
This report covers the impact of COVID-19 on the cryoablation devices market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Boston Scientific, Endocare, Medtronic, and others. The report provides insights into trends, drivers, and limiters of the cryoablation devices market, as well as highlights potential opportunities.
Cryoablation procedures were negatively impacted by the COVID-19 pandemic. The pandemic has had a substantial impact on elective surgical procedures as healthcare resources have been conserved for the treatment of COVID-19 and other critically ill patients.
Boston Scientific is the market leader of the global cryoablation devices market. The company acquired BTG in 2019, which resulted in the company gaining its market-leading position.